They can help determine whether you qualify for a compounded prescription under the new rules and what your next steps should be
Lillys tirzepatide achieved an absence of metabolic dysfunction-associated steatohepatitis without the worsening of fibrosis in more than 50% of patients in a mid-stage study, the company reported Saturday
Nat Commun 17 , 972 (2026)
The issue is not just cost and coverage but providers learning to identify patients who could be covered but are not prescribed because of the complexity of sorting out which insurance plans cover which drugs for which indications
Comply with tax, accounting, recordkeeping, regulatory, court, and law-enforcement obligations
So again, you expect the binding capacity to be near the ideal 8 mg per mL of resin